83 related articles for article (PubMed ID: 20137811)
1. Detangling fibrosis assessment in MPNs.
Mesa RA
Leuk Res; 2010 Jul; 34(7):854-5. PubMed ID: 20137811
[No Abstract] [Full Text] [Related]
2. Quantification of fibrosis and osteosclerosis in myeloproliferative neoplasms: a computer-assisted image study.
Teman CJ; Wilson AR; Perkins SL; Hickman K; Prchal JT; Salama ME
Leuk Res; 2010 Jul; 34(7):871-6. PubMed ID: 20122729
[TBL] [Abstract][Full Text] [Related]
3. Mast cell burden and reticulin fibrosis in the myeloproliferative neoplasms: a computer-assisted image analysis study.
Ahmed A; Powers MP; Youker KA; Rice L; Ewton A; Dunphy CH; Chang CC
Pathol Res Pract; 2009; 205(9):634-8. PubMed ID: 19446406
[TBL] [Abstract][Full Text] [Related]
4. Problems and pitfalls in grading of bone marrow fibrosis, collagen deposition and osteosclerosis - a consensus-based study.
Kvasnicka HM; Beham-Schmid C; Bob R; Dirnhofer S; Hussein K; Kreipe H; Kremer M; Schmitt-Graeff A; Schwarz S; Thiele J; Werner M; Stein H
Histopathology; 2016 May; 68(6):905-15. PubMed ID: 26402166
[TBL] [Abstract][Full Text] [Related]
5. Proplatelet production and stromal fibrosis in myeloproliferative neoplasms.
Wilkins BS
Leuk Res; 2010 Nov; 34(11):1417-9. PubMed ID: 20701970
[No Abstract] [Full Text] [Related]
6. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
7. [The value of the initial bone biopsy in chronic myeloproliferative syndromes. Review of 80 cases].
Ortuño F; Zuazu I; Bordes R; Brunet S; Puig J; Ayats R
Sangre (Barc); 1989 Apr; 34(2):117-25. PubMed ID: 2667169
[TBL] [Abstract][Full Text] [Related]
8. [Diagnostic difficulties in osteomyelosclerosis with myeloid metaplasia in relation to the other components of the myeloproliferative syndrome].
Vilcu A; Hossu T; Popescu ID; Câmpeanu L
Med Interna (Bucur); 1973 Mar; 25(3):363-76. PubMed ID: 4527026
[No Abstract] [Full Text] [Related]
9. Comprehensive bone marrow diagnosis on a single aspiration sample. Plastic sections and cell suspensions for enzyme and immunohisto- and cytochemistry.
van de Sandt MM; Herman CJ; Lindeman J
Pathol Annu; 1987; 22 Pt 1():67-82. PubMed ID: 3554122
[No Abstract] [Full Text] [Related]
10. Plasma basic fibroblast growth factor and bone marrow fibrosis in clonal myeloproliferative disorders.
Sayinalp N; Cinar H; Uner A; Haznedaroğlu IC; Büyükaşik Y; Göker H; Aksu S; Ozcebe OI; Karakuş S; Kirazli S; Dündar SV
Clin Lab Haematol; 2004 Aug; 26(4):265-8. PubMed ID: 15279663
[TBL] [Abstract][Full Text] [Related]
11. Myelofibrosis--what's in a name? Consensus on definition and EUMNET grading.
Thiele J; Kvasnicka HM
Pathobiology; 2007; 74(2):89-96. PubMed ID: 17587880
[TBL] [Abstract][Full Text] [Related]
12. Evolution of bone marrow fibrosis and stromal antigenic expression in chronic myeloid leukemia on alpha interferon and Ara-C therapy.
Straetmans N; Ma DD; Nevell DF; Arthur C
Hematopathol Mol Hematol; 1996; 10(4):213-22. PubMed ID: 9042664
[TBL] [Abstract][Full Text] [Related]
13. Chronic myeloproliferative disorders: the bone marrow stromal component is not involved in the malignant clone.
Di Ianni M; Moretti L; Del Papa B; De Ioanni M; Bonifacio E; Falzetti F; Tabilio A
Leukemia; 2007 Feb; 21(2):377-8. PubMed ID: 17251905
[No Abstract] [Full Text] [Related]
14. Bone marrow fibrosis: pathophysiology and clinical significance of increased bone marrow stromal fibres.
Kuter DJ; Bain B; Mufti G; Bagg A; Hasserjian RP
Br J Haematol; 2007 Nov; 139(3):351-62. PubMed ID: 17910625
[TBL] [Abstract][Full Text] [Related]
15. Hemarthrosis as the presenting manifestation of myeloproliferative disease.
Jackson WH; Harris BK; Ross HA
Ariz Med; 1975 Apr; 32(4):281-3. PubMed ID: 1119948
[No Abstract] [Full Text] [Related]
16. World Health Organization-defined classification of myeloproliferative neoplasms: morphological reproducibility and clinical correlations--the Danish experience.
Madelung AB; Bondo H; Stamp I; Loevgreen P; Nielsen SL; Falensteen A; Knudsen H; Ehinger M; Dahl-Sørensen R; Mortensen NB; Svendsen KD; Lange T; Ralfkiaer E; Nielsen K; Hasselbalch HC; Thiele J
Am J Hematol; 2013 Dec; 88(12):1012-6. PubMed ID: 23897670
[TBL] [Abstract][Full Text] [Related]
17. [The polymorphism of myeloproliferative tumor processes].
Brilliant MD; Domracheva EV; Tikhonova LIu; Vorob'ev AI
Ter Arkh; 1988; 60(5):3-9. PubMed ID: 3175925
[No Abstract] [Full Text] [Related]
18. Rheumatic manifestations in patients with myelodysplastic and myeloproliferative diseases.
Kuzmich PV; Ecker GA; Karsh J
J Rheumatol; 1994 Sep; 21(9):1649-54. PubMed ID: 7799343
[TBL] [Abstract][Full Text] [Related]
19. Myelofibrosis in the myeloproliferative disorders.
Ellis JT; Peterson P
Prog Clin Biol Res; 1984; 154():19-42. PubMed ID: 6382293
[TBL] [Abstract][Full Text] [Related]
20. Automated Osteosclerosis Grading of Clinical Biopsies Using Infrared Spectroscopic Imaging.
Mankar R; Bueso-Ramos CE; Yin CC; Hidalgo-Lopez JE; Berisha S; Kansiz M; Mayerich D
Anal Chem; 2020 Jan; 92(1):749-757. PubMed ID: 31793292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
